Cambridge Cognition Holdings plc (AIM: COG) is a world leading neuroscience technology company committed to enhancing global research, accelerating treatment development and improving patient outcomes in conditions affecting brain health by optimising the assessment of cognition.

For over 30 years, our software has been at the forefront of digital brain health, supporting clients internationally from renowned research institutions and healthcare providers to leading pharmaceutical and biotechnology companies.

Today Cambridge Cognition has developed a sustainable business, positioned for growth, built upon unparalleled scientific heritage and digital health technology innovation.

www.cambridgecognition.com

Visit Cambridge Cognition at stall 81